Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion
HC Wainwright

HC Wainwright Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

Average Return
00.00% 12-Month ROI
Total Ratings
1,933 Last 12 Months
Buy Ratings
1,777 Last 12 Months
Sell Ratings
15 Last 12 Months
Companies Covered
616 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$11.18
+4.7%
5/20/2026Reiterated Rating$15.00BuyView details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 5/20/2026
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$8.05
+3.7%
5/20/2026Reiterated Rating$15.00BuyView details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 5/20/2026
Traws Pharma, Inc. stock logo
TRAW
Traws Pharma
$1.62
+1.9%
5/20/2026Reiterated Rating$8.00BuyView details for HC Wainwright rating of Traws Pharma (NASDAQ:TRAW) on 5/20/2026
Uranium Energy Corp. stock logo
UEC
Uranium Energy
$12.75
+7.1%
5/20/2026Reiterated Rating$26.75BuyView details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 5/20/2026
Vista Gold Corp. stock logo
VGZ
Vista Gold
$2.21
+4.7%
5/20/2026Reiterated Rating$4.50BuyView details for HC Wainwright rating of Vista Gold (NYSEAMERICAN:VGZ) on 5/20/2026
Dogwood Therapeutics, Inc stock logo
DWTX
Dogwood Therapeutics
$1.84
-0.5%
5/19/2026Reiterated Rating$12.00BuyView details for HC Wainwright rating of Dogwood Therapeutics (NASDAQ:DWTX) on 5/19/2026
GH Research PLC stock logo
GHRS
GH Research
$22.54
+2.7%
5/19/2026Lower Price Target$70.00 ➝ $65.00BuyView details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/19/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.59
+26.2%
5/19/2026Reiterated Rating$5.00BuyView details for HC Wainwright rating of MindWalk (NASDAQ:HYFT) on 5/19/2026
Korro Bio, Inc. stock logo
KRRO
Korro Bio
$10.01
+9.4%
5/19/2026Lower Price Target$20.00 ➝ $15.00BuyView details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 5/19/2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$6.19
+0.8%
5/19/2026Lower Price Target$18.00 ➝ $13.00BuyView details for HC Wainwright rating of WAVE Life Sciences (NASDAQ:WVE) on 5/19/2026
Altimmune, Inc. stock logo
ALT
Altimmune
$2.82
+2.9%
5/18/2026Reiterated Rating$25.00 ➝ $20.00BuyView details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 5/18/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$174.45
-0.5%
5/18/2026 UpgradeBuyView details for HC Wainwright rating of Zscaler (NASDAQ:ZS) on 5/18/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$140.34
+7.2%
5/18/2026Boost Price Target$165.00 ➝ $185.00BuyView details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 5/18/2026
Nanobiotix S.A. - Sponsored ADR stock logo
NBTX
Nanobiotix
$43.16
-6.6%
5/18/2026 Reiterated RatingBuyView details for HC Wainwright rating of Nanobiotix (NASDAQ:NBTX) on 5/18/2026
United States Antimony Co. stock logo
UAMY
United States Antimony
$8.33
+11.9%
5/18/2026Boost Price Target$11.50 ➝ $11.75BuyView details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 5/18/2026
Circle Internet Group, Inc. stock logo
CRCL
Circle Internet Group
$111.48
+0.4%
5/18/2026Upgrade$85.00 ➝ $150.00NeutralBuyView details for HC Wainwright rating of Circle Internet Group (NYSE:CRCL) on 5/18/2026
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
$2.51
+4.6%
5/18/2026Reiterated Rating$15.00BuyView details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 5/18/2026
AirJoule Technologies Corporation stock logo
AIRJ
AirJoule Technologies
$3.77
+6.5%
5/18/2026Reiterated Rating$12.00BuyView details for HC Wainwright rating of AirJoule Technologies (NASDAQ:AIRJ) on 5/18/2026
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$50.20
+0.8%
5/18/2026Lower Price Target$55.00 ➝ $50.00NeutralView details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 5/18/2026
CG Oncology, Inc. stock logo
CGON
CG Oncology
$64.76
+2.3%
5/18/2026Reiterated Rating$100.00BuyView details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 5/18/2026
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
$0.58
+4.7%
5/18/2026Reiterated Rating$4.00BuyView details for HC Wainwright rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 5/18/2026
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
$10.72
+3.6%
5/18/2026Reiterated Rating$35.00BuyView details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 5/18/2026
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$302.05
+3.0%
5/18/2026Reiterated Rating$310.00BuyView details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/18/2026
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$28.12
+4.4%
5/18/2026Reiterated Rating$50.00BuyView details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 5/18/2026
MSLE
Satellos Bioscience
$7.36
+5.3%
5/18/2026Reiterated Rating$11.00BuyView details for HC Wainwright rating of Satellos Bioscience (NASDAQ:MSLE) on 5/18/2026
MetaVia Inc. stock logo
MTVA
MetaVia
$2.89
+53.7%
5/18/2026Reiterated Rating$20.00BuyView details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 5/18/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$60.67
+5.5%
5/18/2026Reiterated Rating$120.00BuyView details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 5/18/2026
PMI stock logo
PMI
PMI
$0.15
-3.7%
5/18/2026Initiated CoverageNeutralView details for HC Wainwright rating of PMI (NYSEAMERICAN:PMI) on 5/18/2026
ProKidney Corp. stock logo
PROK
ProKidney
$1.69
+9.0%
5/18/2026Reiterated Rating$12.00BuyView details for HC Wainwright rating of ProKidney (NASDAQ:PROK) on 5/18/2026
Urogen Pharma stock logo
URGN
Urogen Pharma
$30.22
+6.9%
5/18/2026Reiterated Rating$45.00BuyView details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 5/18/2026
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
$15.55
+10.0%
5/18/2026Reiterated Rating$31.00BuyView details for HC Wainwright rating of Vor Biopharma (NASDAQ:VOR) on 5/18/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$34.45
+4.7%
5/15/2026Boost Price Target$52.00 ➝ $57.00BuyView details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 5/15/2026
Electrovaya Inc. stock logo
ELVA
Electrovaya
$10.19
+7.6%
5/15/2026Boost Price Target$10.00 ➝ $15.00BuyView details for HC Wainwright rating of Electrovaya (NASDAQ:ELVA) on 5/15/2026
Alumis Inc. stock logo
ALMS
Alumis
$22.04
+2.4%
5/15/2026Downgrade$25.00BuyNeutralView details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 5/15/2026
Strive, Inc. stock logo
ASST
Strive
$16.98
+5.1%
5/15/2026Boost Price Target$36.00 ➝ $38.00BuyView details for HC Wainwright rating of Strive (NASDAQ:ASST) on 5/15/2026
enCore Energy Corp. stock logo
EU
enCore Energy
$1.41
+1.4%
5/15/2026Lower Price Target$4.00 ➝ $3.75BuyView details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 5/15/2026
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$8.57
-1.5%
5/15/2026Boost Price Target$20.00 ➝ $25.00BuyView details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 5/15/2026
Lisata Therapeutics, Inc. stock logo
LSTA
Lisata Therapeutics
$3.18
+1.9%
5/15/2026DowngradeBuyNeutralView details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 5/15/2026
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
$4.93
+3.4%
5/15/2026DowngradeBuyNeutralView details for HC Wainwright rating of Neuphoria Therapeutics (NASDAQ:NEUP) on 5/15/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$16.27
+2.6%
5/15/2026Boost Price Target$19.00 ➝ $20.00BuyView details for HC Wainwright rating of NeuroPace (NASDAQ:NPCE) on 5/15/2026
From the man who predicted 2008 crash… (Ad)

Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Watch Porter Stansberry's full briefing and learn how to prepare now
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
$31.13
-1.7%
5/15/2026Boost Price Target$28.00 ➝ $50.00BuyView details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 5/15/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$19.56
+9.6%
5/15/2026Reiterated Rating$44.00BuyView details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 5/15/2026
Invivyd, Inc. stock logo
IVVD
Invivyd
$1.09
+4.8%
5/14/2026 Reiterated RatingBuyView details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 5/14/2026
Biogen Inc. stock logo
BIIB
Biogen
$187.80
-1.4%
5/14/2026Reiterated RatingBuyView details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 5/14/2026
Precigen, Inc. stock logo
PGEN
Precigen
$4.27
+2.6%
5/14/2026Boost Price Target$10.00 ➝ $11.00BuyView details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 5/14/2026
Avino Silver & Gold Mines Ltd. stock logo
ASM
Avino Silver & Gold Mines
$6.78
+4.6%
5/14/2026Boost Price Target$13.00BuyView details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/14/2026
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
$1.62
-0.6%
5/14/2026Boost Price Target$9.00 ➝ $10.00BuyView details for HC Wainwright rating of Autolus Therapeutics (NASDAQ:AUTL) on 5/14/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$16.29
+0.1%
5/14/2026Lower Price Target$40.00 ➝ $35.00BuyView details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$3.98
-0.5%
5/14/2026Reiterated Rating$10.00BuyView details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 5/14/2026
Omeros Corporation stock logo
OMER
Omeros
$12.38
+3.4%
5/14/2026Reiterated Rating$40.00BuyView details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 5/14/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$33.40
-1.1%
5/14/2026Reiterated Rating$45.00BuyView details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 5/14/2026
5E Advanced Materials, Inc. stock logo
FEAM
5E Advanced Materials
$1.89
+3.3%
5/13/2026Set Price Target$5.75 ➝ $5.50BuyView details for HC Wainwright rating of 5E Advanced Materials (NASDAQ:FEAM) on 5/13/2026
TII
Titan Mining
$2.37
-0.4%
5/13/2026Lower Price Target$6.75 ➝ $6.50BuyView details for HC Wainwright rating of Titan Mining (NYSEAMERICAN:TII) on 5/13/2026
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$29.01
+7.8%
5/13/2026Reiterated Rating$60.00BuyView details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/13/2026
Franco-Nevada Corporation stock logo
FNV
Franco-Nevada
$225.28
+1.1%
5/13/2026Reiterated Rating$305.00BuyView details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/13/2026
Immunome, Inc. stock logo
IMNM
Immunome
$21.53
+9.5%
5/13/2026Reiterated Rating$40.00BuyView details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 5/13/2026
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$12.26
+2.7%
5/13/2026Lower Price Target$30.00 ➝ $25.00BuyView details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/13/2026
Septerna, Inc. stock logo
SEPN
Septerna
$28.01
+5.7%
5/13/2026Reiterated Rating$40.00BuyView details for HC Wainwright rating of Septerna (NASDAQ:SEPN) on 5/13/2026
First Majestic Silver Corp. stock logo
AG
First Majestic Silver
$19.95
+6.1%
5/12/2026Boost Price Target$30.75BuyView details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/12/2026
Liquidia Corporation stock logo
LQDA
Liquidia
$61.77
+3.0%
5/12/2026Boost Price Target$55.00 ➝ $67.00BuyView details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 5/12/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$10.52
+9.0%
5/12/2026Boost Price Target$15.00 ➝ $20.00BuyView details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 5/12/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$11.18
+4.7%
5/12/2026Boost Price Target$12.00 ➝ $15.00BuyView details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 5/12/2026
Integra Resources Corp. stock logo
ITRG
Integra Resources
$2.49
+2.9%
5/12/2026Lower Price Target$7.00 ➝ $6.75BuyView details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 5/12/2026
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
$7.20
+8.3%
5/12/2026Lower Price Target$48.00 ➝ $38.00BuyView details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 5/12/2026
Oculis Holding AG stock logo
OCS
Oculis
$27.91
-0.2%
5/12/2026Boost Price Target$44.00 ➝ $47.00BuyView details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 5/12/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$6.52
+7.1%
5/12/2026Lower Price Target$30.00 ➝ $25.00BuyView details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/12/2026
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
$3.68
+3.7%
5/12/2026Boost Price Target$7.00 ➝ $10.00BuyView details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/12/2026
Senseonics Holdings, Inc. Common Stock stock logo
SENS
Senseonics Holdings, Inc. Common Stock
$5.71
+3.1%
5/12/2026Lower Price Target$18.50 ➝ $14.00BuyView details for HC Wainwright rating of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) on 5/12/2026
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
$0.85
-0.4%
5/11/2026 Reiterated RatingBuyView details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 5/11/2026
InflaRx N.V. stock logo
IFRX
InflaRx
$2.44
+3.0%
5/11/2026Boost Price Target$6.00 ➝ $8.00BuyView details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 5/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
$45.88
+0.8%
5/11/2026Lower Price Target$95.00 ➝ $64.00BuyView details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 5/11/2026
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
$2.00
+1.5%
5/11/2026Boost Price Target$9.00 ➝ $11.00BuyView details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 5/11/2026
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$78.77
+3.0%
5/11/2026Boost Price Target$136.00 ➝ $140.00BuyView details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/11/2026
Urogen Pharma stock logo
URGN
Urogen Pharma
$30.22
+6.9%
5/11/2026Boost Price Target$40.00 ➝ $45.00BuyView details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 5/11/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$20.77
+1.5%
5/11/2026Reiterated Rating$50.00BuyView details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 5/11/2026
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$68.22
+3.4%
5/11/2026Boost Price Target$100.00 ➝ $110.00BuyView details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 5/11/2026
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
$3.72
+2.2%
5/11/2026Lower Price Target$17.00 ➝ $11.00BuyView details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/11/2026
Keel Infrastructure stock logo
KEEL
Keel Infrastructure
$4.23
+0.5%
5/11/2026Boost Price Target$3.70 ➝ $5.50AccumulateBuyView details for HC Wainwright rating of Keel Infrastructure (NASDAQ:KEEL) on 5/11/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$17.05
+4.2%
5/11/2026Boost Price Target$40.00 ➝ $45.00BuyView details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/11/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$3.75
+2.2%
5/11/2026Lower Price Target$12.00 ➝ $11.00BuyView details for HC Wainwright rating of Niagen Bioscience (NASDAQ:NAGE) on 5/11/2026
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$6.18
+3.2%
5/11/2026Lower Price Target$24.00 ➝ $21.00BuyView details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/11/2026
Coinbase Global, Inc. stock logo
COIN
Coinbase Global
$191.29
-1.1%
5/8/2026Lower Price Target$350.00 ➝ $310.00BuyView details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 5/8/2026
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
$7.84
-8.3%
5/8/2026Boost Price Target$15.00 ➝ $35.00BuyView details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 5/8/2026
Insmed, Inc. stock logo
INSM
Insmed
$107.91
+0.5%
5/8/2026Reiterated RatingBuyView details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 5/8/2026
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
$13.02
+4.8%
5/8/2026Boost Price Target$16.00 ➝ $25.00BuyView details for HC Wainwright rating of Generate Biomedicines (NASDAQ:GENB) on 5/8/2026
Entrada Therapeutics, Inc. stock logo
TRDA
Entrada Therapeutics
$6.04
+6.9%
5/8/2026DowngradeBuyNeutralView details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 5/8/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$48.38
+1.7%
5/8/2026Boost Price Target$58.00 ➝ $65.00BuyView details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 5/8/2026
Vericel Corporation stock logo
VCEL
Vericel
$35.40
+2.6%
5/8/2026Reiterated Rating$64.00BuyView details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 5/8/2026
Energy Fuels Inc stock logo
UUUU
Energy Fuels
$16.78
+3.7%
5/8/2026Boost Price Target$27.25 ➝ $29.00BuyView details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 5/8/2026
enGene Holdings Inc. stock logo
ENGN
enGene
$1.61
+5.2%
5/8/2026Lower Price Target$25.00 ➝ $6.00BuyView details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 5/8/2026
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
IREN Limited stock logo
IREN
IREN
$52.71
+10.4%
5/8/2026Boost Price Target$85.00BuyView details for HC Wainwright rating of IREN (NASDAQ:IREN) on 5/8/2026
Gold Royalty Corp. stock logo
GROY
Gold Royalty
$3.22
+3.2%
5/7/2026Boost Price Target$6.75 ➝ $7.75BuyView details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 5/7/2026
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$96.95
+1.4%
5/7/2026Set Price Target$185.00View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/7/2026
Surrozen, Inc. stock logo
SRZN
Surrozen
$27.05
+5.8%
5/7/2026Reiterated Rating$36.00 ➝ $44.00BuyView details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 5/7/2026
MannKind Corporation stock logo
MNKD
MannKind
$3.25
+9.8%
5/7/2026Boost Price Target$8.00 ➝ $10.00BuyView details for HC Wainwright rating of MannKind (NASDAQ:MNKD) on 5/7/2026
Alto Ingredients, Inc. stock logo
ALTO
Alto Ingredients
$4.67
-1.1%
5/7/2026Boost Price Target$5.50 ➝ $10.00BuyView details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 5/7/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$8.24
+0.2%
5/7/2026Reiterated Rating$24.00BuyView details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 5/7/2026
Exelixis, Inc. stock logo
EXEL
Exelixis
$49.90
+2.5%
5/7/2026Boost Price Target$54.00 ➝ $56.00BuyView details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 5/7/2026
Endeavour Silver Corporation stock logo
EXK
Endeavour Silver
$9.36
+3.8%
5/7/2026Reiterated Rating$17.00BuyView details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 5/7/2026
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$39.76
+0.8%
5/6/2026Boost Price Target$60.00 ➝ $70.00BuyView details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 5/6/2026

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES
32 Believe will outperform the market
UNDERPERFORM VOTES
30 Believe will underperform the market

HC Wainwright's equity research team has issued ratings on 612 companies across 16 sectors over the past 12 months, covered by 35 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Medical (73.2%), Basic Materials (7.1%) and Computer and Technology (3.7%). The chart below shows how HC Wainwright's 616 rated companies are distributed across all 16 sectors it covers.

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 576 companies. Recent upgrades to buy include Zscaler, Circle Internet Group, BioStem Technologies, Airbnb and First Tracks Biotherapeutics.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Andrew Fein, Mitchell Kapoor and Matthew Caufield. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 35 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Medical (73.2% of rated companies), Basic Materials (7.1% of rated companies), Computer and Technology (3.7% of rated companies), Finance (3.4% of rated companies) and Business Services (3.1% of rated companies).

HC Wainwright issued 1,933 ratings over the last 12 months across 616 companies — an average of roughly 161 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.